Millennium Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Millennium Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,088	Closed	-$75K	–	4029
2016 Q3	$75K	Sell	12,088 -13,915	-54%	-$85.8K	﹤0.01%	3159
2016 Q2	$116K	Buy	26,003 +13,952	+116%	+$91.1K	﹤0.01%	2999
2016 Q1	$127K	Sell	12,051 -75,213	-86%	-$1.49M	﹤0.01%	3048
2015 Q4	$2.57M	Buy	87,264 +52,480	+151%	+$1.59M	0.01%	1771
2015 Q3	$1.1M	Sell	34,784 -47,178	-58%	-$2.26M	﹤0.01%	2236
2015 Q2	$4.85M	Buy	81,962 +35,969	+78%	+$2.54M	0.01%	1418
2015 Q1	$4.92M	Buy	45,993 +31,086	+209%	+$2.96M	0.01%	1416
2014 Q4	$1.4M	Sell	14,907 -13,681	-48%	-$1.31M	﹤0.01%	2252
2014 Q3	$2.2M	Buy	28,588 +13,150	+85%	+$1.04M	0.01%	1807
2014 Q2	$1.39M	Buy	+15,438	New	+$946K	﹤0.01%	2002

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's PTX Position: Q4 2016 in Review

Millennium Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 12,088 shares — an estimated $75K sold.

Millennium Management first reported a position in PTX in Q2 2014 and held it in 10 quarters. The position peaked at $4.92M in Q1 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

Millennium Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Millennium Management sold 12,088 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $75K.
Millennium Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 10 quarters.
Millennium Management's Pernix Therapeutics Holdings, Inc. position peaked at $4.92M in Q1 2015.
34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.